Eledon Pharmaceuticals Valuation Multiples

Eledon Pharmaceuticals Overview

About Eledon Pharmaceuticals

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Founded

2004

HQ

Employees

31

Website

eledon.com

Sectors

BiopharmaceuticalsBioTech

Financials (LTM)

Revenue: —

Net Income: ($61M)

EV

$107M

Valuation Multiples

Multiples.vc

Start free trial

Eledon Pharmaceuticals Financials

Eledon Pharmaceuticals reported last 12-month revenue of —.

In the same LTM period, Eledon Pharmaceuticals generated — in gross profit and had net loss of ($61M).

Eledon Pharmaceuticals P&L

In the most recent fiscal year, Eledon Pharmaceuticals reported revenue of — and EBITDA of ($70M).

Eledon Pharmaceuticals expects next 12-month revenue of XXX and NTM EBITDA of XXX

Eledon Pharmaceuticals Stock Performance

Eledon Pharmaceuticals has current market cap of $200M, and enterprise value of $107M.

Eledon Pharmaceuticals' stock price is $2.51.

Eledon Pharmaceuticals Valuation Multiples

Eledon Pharmaceuticals trades at (1.5x) EV/EBITDA.

Eledon Pharmaceuticals Financial Valuation Multiples

As of March 18, 2026, Eledon Pharmaceuticals has market cap of $200M and EV of $107M.

Equity research analysts estimate Eledon Pharmaceuticals' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Eledon Pharmaceuticals has a P/E ratio of (3.3x).

Eledon Pharmaceuticals Margins & Growth Rates

Eledon Pharmaceuticals' revenue in the last fiscal year grew by —.

Eledon Pharmaceuticals' revenue per employee in the last FY averaged $0.0M.

Eledon Pharmaceuticals Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

Eledon Pharmaceuticals M&A Activity

Eledon Pharmaceuticals acquired XXX companies to date.

Last acquisition by Eledon Pharmaceuticals was on XXXXXXXX, XXXXX. Eledon Pharmaceuticals acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Eledon Pharmaceuticals Investment Activity

Eledon Pharmaceuticals invested in XXX companies to date.

Eledon Pharmaceuticals made its latest investment on XXXXXXXX, XXXXX. Eledon Pharmaceuticals invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).